Editors Reads Verdict
Bad Blood is the definitive account of Silicon Valley's most spectacular fraud — Carreyrou's investigative journalism is rendered as thriller narrative without losing any of its documentary precision, making it essential reading for anyone in business, tech, or medicine.
What We Loved
- Carreyrou's journalism is meticulous and his narrative construction is gripping
- The human cost — patients receiving erroneous test results — is never obscured
- Elizabeth Holmes's character is rendered with psychological complexity
- The Silicon Valley culture of grandiosity that enabled the fraud is sharply analyzed
Minor Drawbacks
- Some technical medical detail requires patience from general readers
- The scale of the legal aftermath necessarily exceeds the book's 2018 publication
- A few whistleblower accounts are inevitably partial
Key Takeaways
- → Charisma and vision do not substitute for working technology
- → Silicon Valley's culture of faking-it-till-you-make-it is lethal in healthcare
- → Boards that don't understand the technology they're governing cannot govern it
- → Whistleblowers pay enormous personal costs for institutional honesty
- → Narrative control — Holmes's Steve Jobs persona — can sustain a fraud across years
| Author | John Carreyrou |
|---|---|
| Publisher | Knopf |
| Pages | 339 |
| Published | May 21, 2018 |
| Language | English |
| Genre | Business, Narrative Nonfiction, True Crime |
| Difficulty | Intermediate |
| Best For | Business readers, technology professionals, healthcare workers, and anyone interested in corporate fraud, Silicon Valley culture, and investigative journalism. |
The Fraud That Fooled Everyone
Elizabeth Holmes was nineteen when she dropped out of Stanford to found Theranos. She was thirty-two when John Carreyrou’s Wall Street Journal investigation began unraveling the company’s claims. In between, she had convinced George Shultz, James Mattis, Henry Kissinger, and Rupert Murdoch to sit on her board, raised nearly $1 billion in funding, been named one of Time’s most influential people, and appeared on Forbes covers with a valuation of $9 billion.
None of it was real. The technology — a device that could run hundreds of diagnostic tests from a single finger-prick of blood — didn’t work. The tests Theranos ran for patients used conventional machines operated in violation of industry standards. Patients received false diagnoses. And Holmes, with her baritone voice and black turtleneck and Jobs mythology, maintained the fiction for years through a combination of charisma, legal intimidation, and the profound reluctance of powerful men to admit they had been fooled.
Carreyrou’s Method
Bad Blood works because Carreyrou is, first and foremost, an extraordinary journalist. He cultivated sources for years, protected whistleblowers who took enormous personal risks, and documented everything with Wall Street Journal precision. The book is a model of investigative method rendered as narrative without sacrificing any of its documentary credibility.
The courage of the sources — particularly Tyler Shultz, George Shultz’s grandson, who faced the full weight of Theranos’s legal team — gives the book its moral spine. These are people who knew what the exposure would cost them and provided information anyway.
The Enabling Culture
Carreyrou’s sharpest analysis is reserved not for Holmes but for the system that enabled her. Silicon Valley’s “fake it till you make it” culture — the tolerance for unrealized technology presented as fait accompli — is not criminal in software. Applied to blood diagnostic technology, it can kill people. The board members who failed to ask basic technological questions, the investors who prioritized vision over verification, the culture that mistook conviction for competence — all of it contributed to a fraud that endangered lives.
A Story That Continues
Holmes was convicted of wire fraud in 2022 and sentenced to eleven years. Balwani, Theranos’s president, received a longer sentence. The story Carreyrou broke changed what regulators and investors demand from health technology companies, and changed the cultural conversation about Silicon Valley’s self-mythology.
Our rating: 4.6/5 — The definitive account of the Theranos fraud, reported with extraordinary rigor and written with thriller momentum, essential for anyone trying to understand how Silicon Valley self-delusion becomes mass deception.
Ready to Read Bad Blood?
Check the current price on Amazon.
Check Price on Amazon (paid link)Prices and availability are subject to change. See Amazon for current price.
Review last updated: